Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-02-22 @ 6:46 PM
Study NCT ID:
NCT02115256
Status:
TERMINATED
Last Update Posted:
2017-06-14
First Post:
2014-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline
Sponsor:
Yaakov Beilin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-13
First Submit QC Date:
None
Study First Post Date:
2014-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-31
Results First Submit QC Date:
None
Results First Post Date:
2017-06-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-14
Last Update Post Date:
2017-06-14
Last Update Post Date Type:
ACTUAL